Literature DB >> 17495927

The human RNA kinase hClp1 is active on 3' transfer RNA exons and short interfering RNAs.

Stefan Weitzer1, Javier Martinez.   

Abstract

RNA interference allows the analysis of gene function by introducing synthetic, short interfering RNAs (siRNAs) into cells. In contrast to siRNA and microRNA duplexes generated endogenously by the RNaseIII endonuclease Dicer, synthetic siRNAs display a 5' OH group. However, to become incorporated into the RNA-induced silencing complex (RISC) and mediate target RNA cleavage, the guide strand of an siRNA needs to display a phosphate group at the 5' end. The identity of the responsible kinase has so far remained elusive. Monitoring siRNA phosphorylation, we applied a chromatographic approach that resulted in the identification of the protein hClp1 (human Clp1), a known component of both transfer RNA splicing and messenger RNA 3'-end formation machineries. Here we report that the kinase hClp1 phosphorylates and licenses synthetic siRNAs to become assembled into RISC for subsequent target RNA cleavage. More importantly, we reveal the physiological role of hClp1 as the RNA kinase that phosphorylates the 5' end of the 3' exon during human tRNA splicing, allowing the subsequent ligation of both exon halves by an unknown tRNA ligase. The investigation of this novel enzymatic activity of hClp1 in the context of mRNA 3'-end formation, where no RNA phosphorylation event has hitherto been predicted, remains a challenge for the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17495927     DOI: 10.1038/nature05777

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  94 in total

Review 1.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 2.  RNA interference trigger variants: getting the most out of RNA for RNA interference-based therapeutics.

Authors:  Nicholas M Snead; John J Rossi
Journal:  Nucleic Acid Ther       Date:  2012-06       Impact factor: 5.486

Review 3.  tRNA biology charges to the front.

Authors:  Eric M Phizicky; Anita K Hopper
Journal:  Genes Dev       Date:  2010-09-01       Impact factor: 11.361

4.  Coupled RNA polymerase II transcription and 3' end formation with yeast whole-cell extracts.

Authors:  Luisa Mariconti; Bernhard Loll; Karola Schlinkmann; Agnieszka Wengi; Anton Meinhart; Bernhard Dichtl
Journal:  RNA       Date:  2010-09-01       Impact factor: 4.942

5.  Active site mapping and substrate specificity of bacterial Hen1, a manganese-dependent 3' terminal RNA ribose 2'O-methyltransferase.

Authors:  Ruchi Jain; Stewart Shuman
Journal:  RNA       Date:  2011-01-04       Impact factor: 4.942

Review 6.  Pre-mRNA 3'-end processing complex assembly and function.

Authors:  Serena Chan; Eun-A Choi; Yongsheng Shi
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-10-18       Impact factor: 9.957

Review 7.  Designing highly active siRNAs for therapeutic applications.

Authors:  S Patrick Walton; Ming Wu; Joseph A Gredell; Christina Chan
Journal:  FEBS J       Date:  2010-12       Impact factor: 5.542

8.  Terminal Duplex Stability and Nucleotide Identity Differentially Control siRNA Loading and Activity in RNA Interference.

Authors:  Phillip A Angart; Rebecca J Carlson; Kwasi Adu-Berchie; S Patrick Walton
Journal:  Nucleic Acid Ther       Date:  2016-07-11       Impact factor: 5.486

9.  Transfer RNA as a source of small functional RNA.

Authors:  Megumi Shigematsu; Shozo Honda; Yohei Kirino
Journal:  J Mol Biol Mol Imaging       Date:  2014

10.  Characterization of a thermostable archaeal polynucleotide kinase homologous to human Clp1.

Authors:  Ruchi Jain; Stewart Shuman
Journal:  RNA       Date:  2009-03-19       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.